Trinity Biotech (TRIB) Income towards Parent Company (2009 - 2024)

Trinity Biotech has disclosed Income towards Parent Company across 16 years of filings, most recently posting -$17.0 million for Q4 2024.

• In Q4 2024, Income towards Parent Company fell 208.16% year-over-year to -$17.0 million; the TTM figure through Dec 2024 stood at -$31.8 million (down 32.34% YoY), while the FY2025 annual figure was -$37.4 million, down 17.58% from the prior year.
• Income towards Parent Company came in at -$17.0 million for Q4 2024 at Trinity Biotech, down from -$4.8 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $7.3 million in Q3 2020 to a low of -$17.0 million in Q4 2024.
• Average Income towards Parent Company over 5 years is -$4.9 million, with a median of -$5.7 million recorded in 2023.
• Year-over-year, Income towards Parent Company jumped 29200.0% in 2020 and plunged 1139.59% in 2022.
• Over 5 years, Income towards Parent Company stood at -$10.0 million in 2020, then soared by 87.39% to -$1.3 million in 2021, then tumbled by 697.47% to -$10.1 million in 2022, then surged by 45.42% to -$5.5 million in 2023, then tumbled by 208.16% to -$17.0 million in 2024.
• Per Business Quant data, the three most recent Income towards Parent Company figures were -$17.0 million in Q4 2024, -$4.8 million in Q3 2024, and -$6.8 million in Q2 2024.